CPC-086 Miglustat Off-Label in a Paediatric Formulation for a Rare Metabolic Disease: Early Infantile GM1 Gangliosidosis

European Journal of Hospital Pharmacy: Science and Practice - Belgium
doi 10.1136/ejhpharm-2013-000276.543
Full Text
Abstract

Available in full text

Categories
Pharmacy
Date
Authors
Publisher

BMJ

Related search

GM1 Gangliosidosis Type 1

2020English

Generalized GM1 Gangliosidosis: An Electron-Microscopic Study of the Brain.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1970English

Molecular Consequences of the Pathogenic Mutation in Feline GM1 Gangliosidosis

Molecular Genetics and Metabolism
GeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2008English

DIFFERENTIATION OF TYPES 1, 2 and 3 GM1-GANGLIOSIDOSIS IN SKIN FIBROBLAST CULTURE

Pediatric Research
Child HealthPediatricsPerinatology
1974English

Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2017English

Rapid Detection of GM1 Ganglioside in Cerebrospinal Fluid in Dogs With GM1 Gangliosidosis Using Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry

Journal of Veterinary Diagnostic Investigation
Veterinary
2011English

Off Label Therapies for Testosterone Replacement

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Early Surgery for Infantile Esotropia

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Off-Label Prescribing: A Call for Heightened Professional and Government Oversight

Journal of Law, Medicine and Ethics
MedicineLegal AspectsEthicsIssuesHealth Policy
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy